Thu, May 23, 2013, 6:04 PM EDT - U.S. Markets closed
TTNP was granted FDA priority review for its implant to treat drug addiction.
Millions are hooked on pain meds and illicit drugs.
TTNP has a 6 month slow release abuse proof medication for this epidemic.
A $50,000,000 milestone will be earned on the April 30th approval date plus hefty double digit royalties.
This is serious business!